Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,834 | -884 | -3,827 | -3,077 | -2,201 |
| Accounts payable and accrued liabilities | -106 | 199 | 64 | 219 | 43 |
| Other Working Capital | -290 | 153 | 267 | 347 | 35 |
| Other Operating Activity | 428 | -19 | 1,157 | 812 | 777 |
| Operating Cash Flow | $-1,802 | $-551 | $-2,338 | $-1,699 | $-1,347 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 75 | N/A | N/A |
| Common Stock Issued | 4,699 | 1,857 | 2,663 | 1,334 | 884 |
| Other Financing Activity | -75 | -37 | -12 | 0 | 0 |
| Financing Cash Flow | $4,624 | $1,820 | $2,726 | $1,334 | $884 |
| Exchange Rate Effect | 0 | 3 | -8 | -8 | -7 |
| Beginning Cash Position | 895 | 895 | 515 | 515 | 515 |
| End Cash Position | 3,717 | 2,167 | 895 | 142 | 45 |
| Net Cash Flow | $2,823 | $1,272 | $380 | $-373 | $-470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,802 | -551 | -2,338 | -1,699 | -1,347 |
| Free Cash Flow | -1,802 | -551 | -2,338 | -1,699 | -1,347 |